AtriCure Reports Third Quarter 2024 Financial Results
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Business Wire
Worldwide revenue of $115.9 million – an increase of 17.9% year over yearU.S. revenue of $95.5 million – an increase of 16.8% year over yearAchieved 20% growth on revenues from open appendage management devices in the U.S.International revenue of $20.5 million – an increase of 23.3% year over yearPositive cash flow generation of $16.3 million in third quarter 2024 MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced third quarter 2024 financial results.“Our broad-based growth in the third quarter reflects strong, ongoing adoption trends throughout our business,” said Michael Carrel, President and Chief Executive Officer at AtriCure. “During the quarter, we launched several new products in the United States and Europe, leading to an acceleration in growth along with continued improvement in profita
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure to Participate in the Piper Sandler 36th Annual Healthcare ConferenceBusiness Wire
- AtriCure to Participate in the Stifel 2024 Healthcare ConferenceBusiness Wire
- US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results [Yahoo! Finance]Yahoo! Finance
- AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $49.00 to $53.00. They now have a "buy" rating on the stock.MarketBeat
- AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $32.00 to $36.00. They now have an "outperform" rating on the stock.MarketBeat
ATRC
Earnings
- 10/29/24 - Beat
ATRC
Sec Filings
- 11/14/24 - Form SC
- 11/12/24 - Form SCHEDULE
- 10/30/24 - Form 10-Q
- ATRC's page on the SEC website